Meanwhile, other molecular biomarkers indicating worse outcome in IDH‐mutant astrocytoma, including NOTCH1 mutations and incomplete resections in oligocytoma and PIK3R1 mutations, RB1 mutations and CDK4 mutations and amplifications in astrocytoma.26, 27. Here, IDH1 is linked to astrocytoma (excluding glioblastoma).